Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.
Also called NCT07511543
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Registry
-
NCT07511543
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07511543. Randomized; single masking; primary purpose treatment. Start 2026-10-31 (anticipated); primary completion 2028-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy
- Acronym
- LEAST
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Semaglutide
- Lead sponsor
- Population Health Research Institute
Record details
- Record id
cardio:ct-nct07511543- Content hash
04c6500cb0090469981a002f13a55d8aac76762837406cf40789809fe9a59f74